Home Read more by Molly Bowcott Opens in new window Molly Bowcott joined C+D as a digital reporter in October 2024 after graduating from a masters in journalism at City, University of London
It has been studied for its potential healing properties in animal models, showing promise in the repair of various tissues, including muscles, tendons, and bones
Reddys Laboratories Ltd has launched injectable semaglutide under the brand name Obeda, marking an important step in expanding access to advanced GLP1 receptor agonistbased therapy for the management of type 2 diabetes in India
Posts Tagged glp-1 agonists Weight loss promotions are out of hand on social media, and its endangering patients The internet is overrun with content promoting injectable weight loss medicines and theres no way for viewers to know whether what theyre seeing is legitimate, genuine, safe, or true